Ülkü KÜÇÜK, Ebru ÇAKIR, Yelda DERE, Batuhan ERGANİ, Ozan BOZKURT, Kutsal YÖRÜKOĞLU, Sümeyye EKMEKCİ, Özgür ÇAKMAK, Hatice Ceren SAYAR

8-armed octopus: Evaluation of clinicopathologic prognostic factors of urothelial carcinoma of the upper urinary system

Background/aim: This study was designed to determine the characteristic features of upper urinary system urothelial carcinomas(UUSUCs) and to evaluate the clinicopathological parameters associated with prognosis.Materials and methods: A total of 74 cases of UUSUC were included, from three different centers. Demographic data andhistopathological features such as tumor localization, concomitant tumor in the urinary system, distant metastasis with overall survivaland disease-free survival obtained from the hospital records were evaluated retrospectively. Histopathologic prognostic features such asgrade, perineural invasion, lymphovascular invasion, tumor necrosis, and surgical margin status were also evaluated.Results: Seventy cases (94.6%) underwent open nephroureterectomy whereas 4 cases (5.4%) had laparoscopic nefroureterectomy.Thirty-eight (51.4%) cases were located in the pelvis, 7 (9.5%) in the ureter, 29 (39.2%) both in the pelvis and ureter. Fifty-six (75.7%)cases were alive; however, 18 (24.3%) patients were found to be dead. pTa, pT1, pT2, pT3, and pT4 tumors were reported in 16 (21.6%),13 (17.6%), 4 (5.4%), 28 (37.8%), and 13 (17.6%) patients, respectively. Histopathologically, 17 cases (23%) were low-grade, 57 cases(77%) were high-grade. Statistically significant correlation was observed between overall survival and lymph node metastasis, distantmetastasis, tumor necrosis, and differentiation by univariate analysis. Only distant metastasis was statistically associated with overallsurvival by multivariate analysis. We found no significant relationship between disease-free survival and all parameters.Conclusions: Differentiation and necrosis of tumor, lymph node involvement, and presence of distant metastasis is associated with theoverall survival of urothelial carcinoma of the upper urinary system.

PDF

___

1. Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 2012; 62: 100-114.
2. Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. Int J Urol 2017; 24:730-734.
3. Guo R, Zhu Y, Xiong G, Li X, Zhang K, Zhou L. Role of lymph node dissection in the management of upper tract urothelial carcinomas: a meta-analysis. BMC Urol 2018; 18: 24.
4. Leow JJ, Martin-Doyle W, Fay AP, Choueiri TK, Chang SL, Bellmunt J. A systematic review and metaanalysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 2014; 66: 529-541.
5. Emamekhoo H, Dhillon P, Gopalakrishnan D, Elson P, Stephenson A, Magi-Galluzzi C, McKenney J, Harper H, Haber GP, Kaouk J et al. Prognostic factors and risk stratification in invasive upper tract urothelial carcinoma. Clin Genitourin Cancer 2018; 16: e751-e760.
6. Bolenz C, Fernández MI, Trojan L, Herrmann E, Becker A, Weiss C, Alken P, Ströbel P, Michel MS. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology 2008;72:364-369.
7. Qin C, Liang EL, Du ZY, Qiu XY, Tang G, Chen FR, Zhang B, Tian DW, Hu HL, Wu CL Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinarytract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study. Medicine (Baltimore) 2017; 96: e6945.
8. Gümüş E, Horasanlı K, Tanrıverdi O, Boylu U, Çevik C, Miroğlu C. Üst üriner sistem üretelyal tümörlerinde 10 yıllık klinik deneyimimiz. Turk J Urol 2004; 30: 160-165 (in Turkish).
9. Humphrey PA. urothelial carcinoma of the upper urinary tract. The Journal of Urology 2014; 192: 1223-1224.
10. Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS, Sharia SF. urothelial carcinoma of the bladder and the upper tract: disparate twins. The Journal of Urology 2013; 189: 1214-1221.
11. Kikuchi E, Oya M. Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan. Japanese Journal of Clinical Oncology. 2016; 46:768-774.
12. Zhang XK, Zhang ZL, Yang P, Cai MY, Hu WM, Yun JP, Zhou FJ, Qian CN, Cao Y. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma. Jpn J Clin Oncol 2015; 45:1069-1075.
13. Makise N, Morikawa T, Kawai T, Nakagawa T, Kume H, Homma Y, Fukayama M. Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma. Int J Clin Exp Pathol 2015; 8: 7203-7209.
14. Abdulmajed MI, Sancak EB, Reşorlu B, Al-chalaby GZ. What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future? Turk J Urol 2014; 40: 228-232.
15. van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP. Significant role of lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis.J Urol 2016; 195: 872-879.
16. Kucuk U, Pala EE, Cakır E, Sezer O, Bayol U, Divrik RT, Cakmak O. Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder. Cent European J Urol 2015; 68: 30-36.
17. Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon, France: WHO Press; 2016.
18. Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 2006; 98:1181-1186.
19. Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer 2009; 45: 3291-3297.
20. Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 2006; 176: 48-52.
21. Park J, Ha SH, Min GE, Song C, Hong B, Hong JH, Kim CS, Ahn H. The protective role of renalparenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival. J Urol 2009; 182: 894-899.
22. Kamihira O, Hattori R, Yamaguchi A, Kawa G, Ogawa O, Habuchi T, Kawauchi A, Uozumi J, Yokoi S, Tsujihata M et al. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol 2009; 55: 1397-1409.
23. Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multiinstitutional dataset from 3 European centers. Cancer 2007; 110: 1715-1722.
24. Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ et al. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol 2010; 184: 1895-1900.
25. Kikuchi E, Horiguchi Y, Nakashima J, Hatakeyama N, Matsumoto M, Nishiyama T, Murai M. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 2005; 174: 2120-2123
26. Mason RJ, Kassouf W, Bell DG, Lacombe L, Kapoor A, Jacobsen N, Fairey A, Izawa J, Black P, Tanguay S et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. Urology 2012; 79: 840-845.
27. Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A et al. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. World J Urol 2011; 29: 465-472.
28. Li X, Ma X, Tang L, Wang B, Chen L, Zhang F, Zhang X. Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis. Oncotarget 2016; 8: 62681-62692.
29. Mullerad M, Russo P, Golijanin D, Chen HN, Tsai HH, Donat SM, Bochner BH, Herr HW, Sheinfeld J, Sogani PC, et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004; 172: 2177-2181.
30. Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 2009; 182: 451-458.
31. Cho DS, Hong SY, Kim YK, Kim SI, Kim SJ. Prognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomy. Korean J Urol 2011; 52: 310-316.
32. Huang YC, Chen MF, Shi CS, Shindel AW, Huang CE, Pang ST, Chuang CK, Chen CS, Chang YH, Lin WY et al. The efficacy of postoperative adjuvant chemotherapy for patients with pT3N0M0 upper tract urothelial carcinoma. J Urol 2015; 194: 323-329.